{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T01:35:18Z","timestamp":1773797718500,"version":"3.50.1"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81160045"],"award-info":[{"award-number":["81160045"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81100198"],"award-info":[{"award-number":["81100198"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81170265"],"award-info":[{"award-number":["81170265"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81270285"],"award-info":[{"award-number":["81270285"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Beijing Municipal High-Level Talent Foundation of Health System","award":["2011-1-5"],"award-info":[{"award-number":["2011-1-5"]}]},{"DOI":"10.13039\/501100009331","name":"Beijing Municipal Administration of Hospitals Clinical Medicine Development of Special Funding Support","doi-asserted-by":"crossref","award":["ZY201303"],"award-info":[{"award-number":["ZY201303"]}],"id":[{"id":"10.13039\/501100009331","id-type":"DOI","asserted-by":"crossref"}]},{"name":"National Key Clinical Speciality Construction Project"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.cca.2015.05.018","type":"journal-article","created":{"date-parts":[[2015,6,7]],"date-time":"2015-06-07T07:47:03Z","timestamp":1433663223000},"page":"27-32","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"special_numbering":"C","title":["Circulating chemerin levels elevated in dilated cardiomyopathy patients with overt heart failure"],"prefix":"10.1016","volume":"448","author":[{"given":"Ou","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingwei","family":"Ji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingzhong","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhijian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wensheng","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaofei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianwei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuyang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-jie","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2015.05.018_bb0005","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1161\/01.RES.74.2.182","article-title":"Viral infection and the pathogenesis of dilated cardiomyopathy","volume":"74","author":"Martino","year":"1994","journal-title":"Circ Res"},{"key":"10.1016\/j.cca.2015.05.018_bb0010","doi-asserted-by":"crossref","first-page":"3535","DOI":"10.4049\/jimmunol.173.5.3535","article-title":"C protein-induced myocarditis and subsequent dilated cardiomyopathy: rescue from death and prevention of dilated cardiomyopathy by chemokine receptor DNA therapy","volume":"173","author":"Matsumoto","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.cca.2015.05.018_bb0015","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0065-2776(08)00604-4","article-title":"Pathogenesis of myocarditis and dilated cardiomyopathy","volume":"99","author":"Cihakova","year":"2008","journal-title":"Adv Immunol"},{"key":"10.1016\/j.cca.2015.05.018_bb0020","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1089\/jir.2011.0057","article-title":"Critical cytokine pathways to cardiac inflammation","volume":"31","author":"Rose","year":"2011","journal-title":"J Interferon Cytokine Res"},{"key":"10.1016\/j.cca.2015.05.018_bb0025","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1007\/s00059-004-2626-9","article-title":"Inflammation in dilated cardiomyopathy","volume":"29","author":"Pankuweit","year":"2004","journal-title":"Herz"},{"key":"10.1016\/j.cca.2015.05.018_bb0030","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0008-6363(03)00437-1","article-title":"Myocarditis and dilated cardiomyopathy: an inflammatory link","volume":"60","author":"Mason","year":"2003","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.cca.2015.05.018_bb0035","first-page":"381","article-title":"Plasma concentration of interleukin-6 as a marker of prognosis in patients with chronic congestive heart failure","volume":"90","author":"Tsutamoto","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.cca.2015.05.018_bb0040","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1378\/chest.120.2.453","article-title":"Effects of vesnarinone on peripheral circulating levels of cytokines and cytokine receptors in patients with heart failure: a report from the Vesnarinone Trial","volume":"120","author":"Deswal","year":"2001","journal-title":"Chest"},{"key":"10.1016\/j.cca.2015.05.018_bb0045","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1161\/CIRCRESAHA.112.276519","article-title":"Effects of intracoronary CD34+ stem cell transplantation in nonischemic dilated cardiomyopathy patients: 5-year follow-up","volume":"112","author":"Vrtovec","year":"2013","journal-title":"Circ Res"},{"key":"10.1016\/j.cca.2015.05.018_bb0050","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/j.metabol.2013.06.004","article-title":"Adipocytokines in relation to cardiovascular disease","volume":"62","author":"Van de Voorde","year":"2013","journal-title":"Metabolism"},{"key":"10.1016\/j.cca.2015.05.018_bb0055","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.jjcc.2013.11.006","article-title":"Adipokines: a link between obesity and cardiovascular disease","volume":"63","author":"Nakamura","year":"2014","journal-title":"J Cardiol"},{"key":"10.1016\/j.cca.2015.05.018_bb0060","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.atherosclerosis.2012.12.029","article-title":"Adipokines as mediators of endothelial function and atherosclerosis","volume":"227","author":"Ntaios","year":"2013","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cca.2015.05.018_bb0065","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0828-282X(08)70602-0","article-title":"Relationships of adiponectin and matrix metalloproteinase-9 to tissue inhibitor of metalloproteinase-1 ratio with coronary plaque morphology in patients with acute coronary syndrome","volume":"24","author":"Cheng","year":"2008","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cca.2015.05.018_bb0070","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.jacc.2008.07.073","article-title":"Resistin, adiponectin, and risk of heart failure the Framingham offspring study","volume":"53","author":"Frankel","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cca.2015.05.018_bb0075","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.cardfail.2013.10.004","article-title":"The relationship between leptin and ventilatory control in heart failure","volume":"19","author":"Cundrle","year":"2013","journal-title":"J Card Fail"},{"key":"10.1016\/j.cca.2015.05.018_bb0080","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1016\/j.jacc.2011.06.057","article-title":"Obesity and risk of incident heart failure in older men with and without pre-existing coronary heart disease: does leptin have a role?","volume":"58","author":"Wannamethee","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cca.2015.05.018_bb0085","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1161\/CIRCULATIONAHA.104.530972","article-title":"Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure","volume":"112","author":"Kistorp","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.cca.2015.05.018_bb0090","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1093\/eurheartj\/ehm154","article-title":"Total and high molecular weight adiponectin, haemodynamics, and mortality in patients with chronic heart failure","volume":"28","author":"Tsutamoto","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cca.2015.05.018_bb0095","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1093\/eurheartj\/ehq498","article-title":"Adiponectin expression in patients with inflammatory cardiomyopathy indicates favourable outcome and inflammation control","volume":"32","author":"Bobbert","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cca.2015.05.018_bb0100","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/1523-1747.ep12276660","article-title":"Tazarotene-induced gene 2 (TIG2), a novel retinoid-responsive gene in skin","volume":"109","author":"Nagpal","year":"1997","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.cca.2015.05.018_bb0105","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1084\/jem.20030382","article-title":"Specific recruitment of antigen-presenting cells by chemerin, a novel processed ligand from human inflammatory fluids","volume":"198","author":"Wittamer","year":"2003","journal-title":"J Exp Med"},{"key":"10.1016\/j.cca.2015.05.018_bb0110","doi-asserted-by":"crossref","first-page":"28175","DOI":"10.1074\/jbc.M700793200","article-title":"Chemerin, a novel adipokine that regulates adipogenesis and adipocyte metabolism","volume":"282","author":"Goralski","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cca.2015.05.018_bb0115","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s12020-012-9698-8","article-title":"Chemerin: a potential endocrine link between obesity and type 2 diabetes","volume":"42","author":"Roman","year":"2012","journal-title":"Endocrine"},{"key":"10.1016\/j.cca.2015.05.018_bb0120","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.1210\/en.2009-0794","article-title":"Serum chemerin levels vary with time of day and are modified by obesity and tumor necrosis factor-\u03b1","volume":"151","author":"Parlee","year":"2010","journal-title":"Endocrinology"},{"key":"10.1016\/j.cca.2015.05.018_bb0125","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.regpep.2009.02.010","article-title":"Interleukin-1\u03b2 induces the novel adipokine chemerin in adipocytes in vitro","volume":"154","author":"Kralisch","year":"2009","journal-title":"Regul Pept"},{"key":"10.1016\/j.cca.2015.05.018_bb0130","doi-asserted-by":"crossref","first-page":"487","DOI":"10.4049\/jimmunol.175.1.487","article-title":"Neutrophil-mediated maturation of chemerin: a link between innate and adaptive immunity","volume":"175","author":"Wittamer","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.cca.2015.05.018_bb0135","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s12020-011-9550-6","article-title":"The association of serum chemerin level with risk of coronary artery disease in Chinese adults","volume":"41","author":"Yan","year":"2012","journal-title":"Endocrine"},{"key":"10.1016\/j.cca.2015.05.018_bb0140","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/1475-2840-10-87","article-title":"Association of chemerin mRNA expression in human epicardial adipose tissue with coronary atherosclerosis","volume":"10","author":"Gao","year":"2011","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.cca.2015.05.018_bb0145","doi-asserted-by":"crossref","first-page":"e113915","DOI":"10.1371\/journal.pone.0113915","article-title":"Association between serum chemerin concentrations and clinical indices in obesity or metabolic syndrome: a meta-analysis","volume":"9","author":"Li","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.cca.2015.05.018_bb0150","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/j.1365-2265.2009.03664.x","article-title":"Systemic chemerin is related to inflammation rather than obesity in type 2 diabetes","volume":"72","author":"Weigert","year":"2010","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.cca.2015.05.018_bb0155","doi-asserted-by":"crossref","first-page":"R158","DOI":"10.1186\/ar3475","article-title":"Chemerin activates fibroblast-like synoviocytes in patients with rheumatoid arthritis","volume":"13","author":"Kaneko","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.cca.2015.05.018_bb0160","first-page":"243","article-title":"Levels of chemerin and interleukin 8 in the synovial fluid of patients with inflammatory arthritides and osteoarthritis","volume":"32","author":"Valcamonica","year":"2014","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.cca.2015.05.018_bb0165","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s12933-014-0145-4","article-title":"Chemerin is a novel biomarker of acute coronary syndrome but not of stable angina pectoris","volume":"13","author":"Ji","year":"2014","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.cca.2015.05.018_bb0170","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/S0002-9149(98)00872-8","article-title":"Cytokine network in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy","volume":"83","author":"Aukrust","year":"1999","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cca.2015.05.018_bb0175","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1016\/S0735-1097(01)01299-2","article-title":"Relationship between tumor necrosis factor-\u03b1 production and oxidative stress in the failing hearts of patients with dilated cardiomyopathy","volume":"37","author":"Tsutamoto","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cca.2015.05.018_bb0180","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1161\/01.CIR.103.16.2055","article-title":"Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the Vesnarinone trial (VEST)","volume":"103","author":"Deswal","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.cca.2015.05.018_bb0185","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.jacc.2005.06.088","article-title":"Atorvastatin improves left ventricular systolic function and serum markers of inflammation in nonischemic heart failure","volume":"47","author":"Sola","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cca.2015.05.018_bb0190","doi-asserted-by":"crossref","first-page":"3728","DOI":"10.4049\/jimmunol.0902154","article-title":"Chemerin contributes to inflammation by promoting macrophage adhesion to VCAM-1 and fibronectin through clustering of VLA-4 and VLA-5","volume":"185","author":"Hart","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.cca.2015.05.018_bb0195","doi-asserted-by":"crossref","first-page":"R228","DOI":"10.1186\/ar3215","article-title":"Human articular chondrocytes express ChemR23 and chemerin; ChemR23 promotes inflammatory signalling upon binding the ligand chemerin(21\u2013157)","volume":"12","author":"Berg","year":"2010","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.cca.2015.05.018_bb0200","doi-asserted-by":"crossref","first-page":"5457","DOI":"10.4049\/jimmunol.1003862","article-title":"The role of ChemR23 in the induction and resolution of cigarette smoke-induced inflammation","volume":"186","author":"Demoor","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.cca.2015.05.018_bb0205","doi-asserted-by":"crossref","first-page":"326","DOI":"10.3109\/10641963.2013.827697","article-title":"Chemerin is associated with inflammatory markers and metabolic syndrome phenotypes in hypertension patients","volume":"36","author":"Gu","year":"2014","journal-title":"Clin Exp Hypertens"},{"key":"10.1016\/j.cca.2015.05.018_bb0210","doi-asserted-by":"crossref","first-page":"698","DOI":"10.12659\/MSM.890784","article-title":"Evaluation of plasma chemerin levels in patients with non-dipper blood pressure patterns","volume":"20","author":"Meric","year":"2014","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.cca.2015.05.018_bb0215","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1530\/EJE-09-0380","article-title":"Chemerin is associated with markers of inflammation and components of the metabolic syndrome but does not predict coronary atherosclerosis","volume":"161","author":"Lehrke","year":"2009","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.cca.2015.05.018_bb0220","first-page":"R577","article-title":"Tumor necrosis factor in the heart","volume":"274","author":"Meldrum","year":"1998","journal-title":"Am J Physiol"},{"key":"10.1016\/j.cca.2015.05.018_bb0225","series-title":"Myocarditis: from bench to bedside","first-page":"109","article-title":"Cytokines in experimental myocarditis","author":"Matsumori","year":"2003"},{"issue":"5","key":"10.1016\/j.cca.2015.05.018_bb0230","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1002\/eji.201141436","article-title":"Mitochondria: sovereign of inflammation?","volume":"41","author":"Tschopp","year":"2011","journal-title":"Eur J Immunol"},{"issue":"18","key":"10.1016\/j.cca.2015.05.018_bb0235","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1007\/s00018-012-0962-0","article-title":"Mitochondrial dysfunction and oxidative stress activate inflammasomes: impact on the aging process and age-related diseases","volume":"69","author":"Salminen","year":"2012","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"10.1016\/j.cca.2015.05.018_bb0240","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/nrcardio.2014.189","article-title":"Heart failure: mitochondrial dysfunction and oxidative stress in CHF","volume":"12","author":"Okonko","year":"2015","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.cca.2015.05.018_bb0245","doi-asserted-by":"crossref","DOI":"10.1111\/jcmm.12487","article-title":"Chemerin-induced mitochondrial dysfunction in skeletal muscle","author":"Xie","year":"2015","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.cca.2015.05.018_bb0250","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1084\/jem.20071601","article-title":"Synthetic chemerin-derived peptides suppress inflammation through ChemR23","volume":"205","author":"Cash","year":"2008","journal-title":"J Exp Med"},{"key":"10.1016\/j.cca.2015.05.018_bb0255","doi-asserted-by":"crossref","first-page":"6489","DOI":"10.4049\/jimmunol.0901037","article-title":"Mouse ChemR23 is expressed in dendritic cell subsets and macrophages, and mediates an anti-inflammatory activity of chemerin in a lung disease model","volume":"183","author":"Luangsay","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.cca.2015.05.018_bb0260","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.bbrc.2012.05.103","article-title":"A novel adipocytokine, chemerin exerts anti-inflammatory roles in human vascular endothelial cells","volume":"423","author":"Yamawaki","year":"2012","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.cca.2015.05.018_bb0265","doi-asserted-by":"crossref","first-page":"5315","DOI":"10.4049\/jimmunol.0903378","article-title":"Chemerin peptides promote phagocytosis in a ChemR23- and Syk-dependent manner","volume":"184","author":"Cash","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.cca.2015.05.018_bb0270","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s10741-010-9168-4","article-title":"Proinflammatory cytokines in heart failure: double-edged swords","volume":"15","author":"Hedayat","year":"2010","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.cca.2015.05.018_bb0275","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ejps.2013.08.031","article-title":"Results from a 12months, randomized, clinical trial comparing an olmesartan\/amlodipine single pill combination to olmesartan and amlodipine monotherapies on blood pressure and inflammation","volume":"1","author":"Derosa","year":"2014","journal-title":"Eur J Pharm Sci"}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000989811500279X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000989811500279X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T09:06:10Z","timestamp":1589533570000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000989811500279X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":55,"alternative-id":["S000989811500279X"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2015.05.018","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Circulating chemerin levels elevated in dilated cardiomyopathy patients with overt heart failure","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2015.05.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}